Alzheimer’s dementia: budget impact and cost-utility analysis of a combination treatment with a cholinesterase inhibitor and memantine in Switzerland. (2012). Swiss Medical Weekly, 142(4748), w13676. https://doi.org/10.4414/smw.2012.13676